Date: 2015-01-22
Type of information: Nomination
Compound:
Company: BioInvent (Sweden)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On January 22, 2015, BioInvent International announced that Anna Wickenberg has been appointed as Vice President Clinical Development, responsible for the clinical development of BioInvent’s drug development projects. She will be part of the Management group and reports to the CEO. Anna Wickenberg (born 1974) holds PhD in Medical Sciences, Immunology, and a MSc in Molecular Biology. She has 15 years of experience of leading clinical development projects from various positions at Teva Pharmaceuticals, NeuroSearch, and AstraZeneca. Most recently, Anna was responsible for the clinical development of new chemical entities in an orphan indication within CNS at Teva.
Financial terms:
Latest news:
